Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-09-28
2010-06-01
Davis, Zinna N (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S340000, C514S352000, C544S320000, C546S268400, C546S308000
Reexamination Certificate
active
07727996
ABSTRACT:
Disclosed are compounds which bind VLA-4. Certain of these compounds also inhibit leukocyte adhesion and, in particular, leukocyte adhesion mediated by VLA-4. Such compounds are useful in the treatment of inflammatory diseases in a mammalian patient, e.g., human, such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation, tumor metastasis and myocardial ischemia. The compounds can also be administered for the treatment of inflammatory brain diseases such as multiple sclerosis.
REFERENCES:
patent: 4018913 (1977-04-01), Okamoto et al.
patent: 4018915 (1977-04-01), Okamoto et al.
patent: 4036955 (1977-07-01), Okamoto et al.
patent: 4041156 (1977-08-01), Okamoto et al.
patent: 4046876 (1977-09-01), Okamoto et al.
patent: 4055636 (1977-10-01), Okamoto et al.
patent: 4055651 (1977-10-01), Okamoto et al.
patent: 4070457 (1978-01-01), Okamoto et al.
patent: 4073914 (1978-02-01), Kikumoto et al.
patent: 4085057 (1978-04-01), Masuda et al.
patent: 4096255 (1978-06-01), Kikumoto et al.
patent: 4104392 (1978-08-01), Okamoto et al.
patent: 4235871 (1980-11-01), Papahadjopoulos et al.
patent: 4438122 (1984-03-01), Holmwood et al.
patent: 4501728 (1985-02-01), Geho et al.
patent: 4505910 (1985-03-01), Bagli
patent: 4518600 (1985-05-01), Holmwood et al.
patent: 4544402 (1985-10-01), Schnurbusch et al.
patent: 4559345 (1985-12-01), Gomarasca et al.
patent: 4672065 (1987-06-01), Spatz
patent: 4837028 (1989-06-01), Allen et al.
patent: 4908368 (1990-03-01), Murase et al.
patent: 4959364 (1990-09-01), Mueller et al.
patent: 4992439 (1991-02-01), Meanwell
patent: 5011472 (1991-04-01), Aebischer et al.
patent: 5023252 (1991-06-01), Hseih et al.
patent: 5030644 (1991-07-01), Baldwin et al.
patent: 5120734 (1992-06-01), Klausener et al.
patent: 5238934 (1993-08-01), Knuppel et al.
patent: 5278184 (1994-01-01), Artico et al.
patent: 5510332 (1996-04-01), Kogan et al.
patent: 5580868 (1996-12-01), Lunkenheimer et al.
patent: 5770573 (1998-06-01), Arrhenius et al.
patent: 5814643 (1998-09-01), Duggan et al.
patent: 5861429 (1999-01-01), Sato et al.
patent: 5925644 (1999-07-01), Jakobi et al.
patent: 5942504 (1999-08-01), Grobelny
patent: 5955491 (1999-09-01), Sohda et al.
patent: 5962479 (1999-10-01), Chen
patent: 5972946 (1999-10-01), Murata et al.
patent: 6005117 (1999-12-01), Wehner et al.
patent: 6436904 (2002-08-01), Ashwell et al.
patent: 6479492 (2002-11-01), Konradi et al.
patent: 6492372 (2002-12-01), Konradi et al.
patent: 6544994 (2003-04-01), Rabelink et al.
patent: 6545003 (2003-04-01), Grant et al.
patent: 6689781 (2004-02-01), Konradi et al.
patent: 6794506 (2004-09-01), Konradi et al.
patent: 6903088 (2005-06-01), Konradi et al.
patent: 6911439 (2005-06-01), Konradi et al.
patent: 7005433 (2006-02-01), Konradi et al.
patent: 7008949 (2006-03-01), Konradi et al.
patent: 7026328 (2006-04-01), Konradi et al.
patent: 7049306 (2006-05-01), Konradi et al.
patent: 7135477 (2006-11-01), Konradi et al.
patent: 7335663 (2008-02-01), Konradi et al.
patent: 7378529 (2008-05-01), Konradi et al.
patent: 7427628 (2008-09-01), Konradi et al.
patent: 7452912 (2008-11-01), Grant et al.
patent: 2005/0203093 (2005-09-01), Konradi et al.
patent: 2005/0261293 (2005-11-01), Konradi et al.
patent: 2006/0013799 (2006-01-01), Konradi et al.
patent: 2007/0099921 (2007-05-01), Konradi et al.
patent: 2007/0129390 (2007-06-01), Semko et al.
patent: 2007/0142416 (2007-06-01), Semko
patent: 2008/0058357 (2008-03-01), Smith et al.
patent: 2241149 (1997-07-01), None
patent: 2259224 (1998-01-01), None
patent: 2359115 (2000-07-01), None
patent: 195 36 891 (1997-04-01), None
patent: 265 56 36 (1997-06-01), None
patent: 195 48 709 (1997-07-01), None
patent: 196 54 483 (1998-01-01), None
patent: 197 13 000 (1998-10-01), None
patent: 116494 (1984-08-01), None
patent: 0 147 211 (1985-07-01), None
patent: 0 288 176 (1988-10-01), None
patent: 0330506 (1989-08-01), None
patent: 0 526 348 (1993-02-01), None
patent: 0 535 521 (1993-04-01), None
patent: 1500063 (1978-02-01), None
patent: 169926 (1977-02-01), None
patent: 59212480 (1984-12-01), None
patent: WO 91/05038 (1991-04-01), None
patent: WO 92/16549 (1992-10-01), None
patent: WO 93/12809 (1993-07-01), None
patent: WO 93/24154 (1993-12-01), None
patent: WO 96/01644 (1996-01-01), None
patent: WO 96/22966 (1996-08-01), None
patent: WO 96/32383 (1996-10-01), None
patent: WO 97/23451 (1997-07-01), None
patent: WO 97/48726 (1997-12-01), None
patent: WO 98/00395 (1998-01-01), None
patent: WO 98/22430 (1998-05-01), None
patent: WO 98/33783 (1998-08-01), None
patent: WO 98/53814 (1998-12-01), None
patent: WO 98/53817 (1998-12-01), None
patent: WO 99/06390 (1999-02-01), None
patent: WO 99/06391 (1999-02-01), None
patent: WO 99/06431 (1999-02-01), None
patent: WO 99/06432 (1999-02-01), None
patent: WO 99/06433 (1999-02-01), None
patent: WO 99/10312 (1999-03-01), None
patent: WO 99/10313 (1999-03-01), None
patent: WO 99/37605 (1999-07-01), None
patent: WO 99/37618 (1999-07-01), None
patent: WO 99/52898 (1999-10-01), None
patent: WO 00/18759 (2000-04-01), None
patent: WO 00/31067 (2000-06-01), None
patent: WO 00/43369 (2000-07-01), None
patent: WO 00/43371 (2000-07-01), None
patent: WO 00/43372 (2000-07-01), None
patent: WO 02/08201 (2002-01-01), None
patent: WO 03/099231 (2003-12-01), None
patent: WO 03/099809 (2003-12-01), None
patent: WO 2005/111020 (2005-11-01), None
patent: WO 2007/041270 (2007-04-01), None
patent: WO 2007/041324 (2007-04-01), None
patent: WO 2007/101165 (2007-09-01), None
Abraham et al., “α4-Integrins Mediate Antigen-induced Late Bronchial Responses and Prolonged Airway Hyperresponsiveness in Sheep”J. Clin. Invest. 93:776-787 (1994).
Abraham et al. “Blockade of Late-phase Airway Rsponses and Airway Hyperresponsiveness in Allergic Sheep with a Small-molecule Peptide Inhibitor of VLA-4”Am. J. Respir. Crit. Care Med. 156:696-703 (1997).
Anderson et al. “Acute kidney graft rejection”APMIS102:23-37 (1994).
Bao et al. “Correlation of VLA-4 integrin expression with metastatic potential in various human tumour cell lines”Diff. 52:239-246 (1993).
Baron et al. “Surface Expression of α4 Integrin by CD4 T Cells Is Required for Their Entry into Brain Parenchyma”J. Exp. Med. 177:57-68 (1993).
Baron et al. “The Pathogenesis of Adoptive Murine Autoimmune Diabetes Requires an Interaction between α4-Integrins and Vascular Cell Adhesion Molecule”J. Clin. Invest., 93:1700-1708 (1994).
Belka, et al. “Radiation induced CNS toxicity—molecular and cellular mechanisms”Br. J. Cancer85:1233-1239 (2001).
Burkly et al. “Protection Against Adoptive Transfer of Autoimmune Diabetes Mediated Through Very Late Antigen-4 Integrin”Diabetes43:529-534 (1994).
Chapman et al. “Time Course of Allergen-Induced Leucocyte Accumulation in Actively Sensitized Brown Norway Rats”Am. J. Resp. Crit. Care Med. 153-154, A219 (1996).
Chapman et al. “Allergen-Induced Airway Hyperreactivity and Eosinophil Accumulation Are Temporarally Dissociated in Actively Sensitized Brown Norway Rats”Am. J. Resp. Crit. Care Med. 155-154, A881 (1997).
Chang, Yi-Han “Mechanisms Underlying the Supression of Adjuvant-Induced Arthritis by 6-Mercaptopurine”Arth. Rheum. 20:1135-1141 (1977).
Chen, et al. “Mediation of sperm-egg fusion: evidence that mouse egg α6β1integrin is the receptor for sperm fertilinβ”Chem Biol. 6:1-10 (1999).
Cybulsky et al. “Endothelial Expression of a Mononuclear Leukocyte Adhesion Molecule During Atherogenesis”Science251:788-791 (1991).
Elewaut, et al. “Distinctive Activated Cellular Subsets in Colon from Patients with Crohn's Disease and Ulcerative Colitis”Scand. J. Gastroenterol33:743-748 (1998).
Elices et al., “VCAM-1 on Activated Endothelium Interacts with the Leukocyte Integrin VLA-4 at a Site Distince from the VLA-4/Fibronectin Binding Site”Cell60:577-584 (1990).
Elices
Fukuda Juri Y.
Konradi Andrei W.
Rossiter Kassandra Inez
Semko Christopher Michael
Smith Jenifer Lea
Davis Zinna N
Elan Pharmaceuticals Inc.
Swiss Tanner, P.C.
Wyeth
LandOfFree
Carbamate compounds which inhibit leukocyte adhesion... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carbamate compounds which inhibit leukocyte adhesion..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carbamate compounds which inhibit leukocyte adhesion... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4178096